Lilleyman JS - Search Results

1

Caution in regard to treatment of hemangiomas with interferon alfa-2a.

Vora AJ, Lilleyman JS. Vora AJ, et al. Among authors: lilleyman js. N Engl J Med. 1992 Oct 29;327(18):1321-2. doi: 10.1056/NEJM199210293271819. N Engl J Med. 1992. PMID: 1489461 No abstract available.

2

Wolfram syndrome: mitochondrial disorder.

Vora AJ, Lilleyman JS. Vora AJ, et al. Among authors: lilleyman js. Lancet. 1993 Oct 23;342(8878):1059. Lancet. 1993. PMID: 8105295 No abstract available.

3

Secondary thrombocytosis.

Vora AJ, Lilleyman JS. Vora AJ, et al. Among authors: lilleyman js. Arch Dis Child. 1993 Jan;68(1):88-90. doi: 10.1136/adc.68.1.88. Arch Dis Child. 1993. PMID: 8435017 Free PMC article.

4

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.

Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J, Richards SM; Medical Research Council; National Cancer Research Network Childhood Leukaemia Working Party. Vora A, et al. Lancet. 2006 Oct 14;368(9544):1339-48. doi: 10.1016/S0140-6736(06)69558-5. Lancet. 2006. PMID: 17046466 Clinical Trial.

5

Frequency and importance of change in blast cell karyotype in relapsing childhood lymphoblastic leukemia.

Vora AJ, Potter AM, Anderson LM, Lilleyman JS. Vora AJ, et al. Among authors: lilleyman js. Pediatr Hematol Oncol. 1994 Jul-Aug;11(4):379-86. doi: 10.3109/08880019409140537. Pediatr Hematol Oncol. 1994. PMID: 7947010

6

Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.

Lancaster DL, Lennard L, Rowland K, Vora AJ, Lilleyman JS. Lancaster DL, et al. Among authors: lilleyman js. Br J Haematol. 1998 Jul;102(2):439-43. doi: 10.1046/j.1365-2141.1998.00812.x. Br J Haematol. 1998. PMID: 9695957

7

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.

Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, Kinsey S, Mitchell C, Eden OB. Hann I, et al. Leukemia. 2000 Mar;14(3):356-63. doi: 10.1038/sj.leu.2401704. Leukemia. 2000. PMID: 10720126 Clinical Trial.

8

Late relapsing childhood lymphoblastic leukemia.

Vora A, Frost L, Goodeve A, Wilson G, Ireland RM, Lilleyman J, Eden T, Peake I, Richards S. Vora A, et al. Blood. 1998 Oct 1;92(7):2334-7. Blood. 1998. PMID: 9746771 Free article.

9

Intraocular relapse of childhood acute lymphoblastic leukaemia.

Somervaille TC, Hann IM, Harrison G, Eden TO, Gibson BE, Hill FG, Mitchell C, Kinsey SE, Vora AJ, Lilleyman JS; MRC Childhood Leukaemia Working Party. Somervaille TC, et al. Among authors: lilleyman js. Br J Haematol. 2003 Apr;121(2):280-8. doi: 10.1046/j.1365-2141.2003.04280.x. Br J Haematol. 2003. PMID: 12694250

10

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.

Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TO; Medical Research Council Childhood Leukaemia Working Party. Mitchell CD, et al. Br J Haematol. 2005 Jun;129(6):734-45. doi: 10.1111/j.1365-2141.2005.05509.x. Br J Haematol. 2005. PMID: 15952999 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters